insights_auto
Why is LPCN up 5.56%?
Dive Deeperchevron_right
LPCN:NASDAQ
Lipocine Inc
$1.71
arrow_upward
+5.56%(+0.090) 1D
$1.72
arrow_upward
+0.58% (+0.0100)bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LPCN...
Open
$1.63
High
$1.75
Low
$1.53
Mkt. cap
18.94M
Avg. vol.
3.86M
Volume
215.11K
52-wk high
$12.37
52-wk low
$1.36
EPS
-$1.36
Beta
0.49
Shares outstanding
11.07M
No. of employees
14
Open
$1.63
High
$1.75
Low
$1.53
Mkt. cap
18.94M
Avg. vol.
3.86M
Volume
215.11K
52-wk high
$12.37
52-wk low
$1.36
EPS
-$1.36
Beta
0.49
Shares outstanding
11.07M
No. of employees
14
News stories
From web sources and news partners
Investing.com
·
1 hour ago
Lipocine CEO Mahesh Patel buys $79,487 in company stock Nov 12-13.
GuruFocus
·
12 hours ago
Lipocine (LPCN) CEO Mahesh Patel Buys 50,000 Shares, Lifting Ins
Quantisnow
·
14 hours ago
Lipocine (LPCN) CEO Patel bought 50,000 shares for $79.5K at an average $1.59
About Lipocine Inc
CEO-
Employees14
Founded1997
HeadquartersSalt Lake City, Utah, United States
SectorHealth Care
IndustryPharmaceutical industry
Websitelipocine.com